MAOI efficacy and safety in advanced stage treatment-resistant depression—A retrospective study
- 1 December 2005
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 89 (1-3) , 183-188
- https://doi.org/10.1016/j.jad.2005.06.011
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effectiveness and Feasibility of a Standardized Stepwise Drug Treatment Regimen Algorithm for Inpatients With Depressive DisordersThe Journal of Clinical Psychiatry, 2002
- Strengthening clinical effectiveness trials: Equipoise-stratified randomizationBiological Psychiatry, 2001
- Monoamine Oxidase Inhibitors RevisitedPsychiatric Annals, 2001
- Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology, 2000
- On eliminating the asymptotic bias in the quasi-least squares estimate of the correlation parameterJournal of Statistical Planning and Inference, 1999
- Analysis of Serially Correlated Data Using Quasi-Least SquaresPublished by JSTOR ,1998
- Fluoxetine efficacy in treatment resistant depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1994
- Treatment strategy in depressionActa Psychiatrica Scandinavica, 1988
- Treatment strategy in depressionActa Psychiatrica Scandinavica, 1988
- L-5HTP in Depression Resistant to Re-Uptake InhibitorsThe British Journal of Psychiatry, 1985